We have recently commenced a new clinical trial testing a new device called RespiraSense which is worn on a patients chest and measures breathing rate continuously and wearable finger probe that continuously oxygen sats and pulse.
The trial "Continuous respiratory rate and pulse oximetry monitoring using wearable sensors for early detection of clinical deterioration" is funded by NHS Transformation Directorate and led by Investigator Dr Dr Sherif Gonem from Nottingham University Hospitals NHS Trust and NIHR Nottingham BRC Respiratory Theme.
What is the purpose of the study?
While you are in hospital, nurses will normally check your vital signs every 4 hours or so to make sure you are ok. These include your oxygen sats, pulse and breathing rate. We are currently testing a new device called RespiraSense which is worn on your chest and measures your breathing rate continuously. You may also have been given a finger probe to wear which continuously monitors your oxygen sats and pulse. This is so that nurses on the ward can tell straight away if your condition is getting worse. These devices have already been approved for clinical use by the regulatory authorities. They will be worn for around 5 days, and potentially as long as you stay in hospital.
The purpose of this study is to understand how these monitoring devices could benefit patients in hospital. We want to find out if monitoring vital signs continuously using wearable devices is better than measuring them every 4 hours. We will do this by checking if the wearable devices pick up problems sooner than the routine checks would have done.